Conflict of interest
Authors, reviewers, editors and member of editorial board might have a potential conflict of interest which might in a significant extent affect their research activities, opinions and judgement. This is especially problematic when behind the public actions private benefits exist which might result in the personal gains. There is a wide range of the possible conflicting situations such as financial interest of the participants by affiliating with the commercial organizations in the form of grants, honorary jobs, employments, consultancies etc, and non-financial interest such as personal and professional relationships.
All participants involved in the ADMET and DMPK publication process must consider and disclose their potential conflicting interest while in the process of article submission, review and publication.
Authors submitting a manuscript to ADMET and DMPK are obliged to disclose all relationships and activities that might bias their work. A declaration of any conflict of interest must accompany the manuscript as a statement(s) to be published in the accepted version of the manuscript. In addition, a Disclosure Form must be filled in before the accepted article appears online. The corresponding author represents all co-authors and is responsible to get information concerning the eventual conflict of interest of all co-authors. Authors reporting the results obtained in the organization of their employment must declare it as a potential conflict of interest. Authors should adhere to the Good Publication Practice guidelines for pharmaceutical companies (GPP3).
What to disclose
- Employment status, direct or indirect
- Honorarium involvement with the potentially conflicting company including consultancies, writing fees and others
- Grants or other received research funding
- Patents and pending patent applications
- Investments in the stock ownership or others
- Any personal, professional or political relationship which might influence the investigated research or opinion.
During the invitations of the reviewers to evaluate a manuscript they are warned and asked to identify any possible conflicting relationship either with the authors, those being of personal of professional nature, or with the companies with their possible interest either for publishing the results or opposing them. The reviewers should in the communications with Editors state explicitly whether one of these conflicting situations exists.
Editors and Editorial Teams members
ADMET and DMPK pays special attention to evaluate manuscripts submitted by individuals involved in editorial team. ADMET and DMPK follows strict guidance in these matters available from COPE and WAME.